-
Placebo rates in randomised clinical trials of ulcerative colitis [Elektronski vir] : an individual patient data meta-analysisSolitano, Virginia ...Background and aims: We assessed placebo rates and associated factors using individual patient data (IDP) from randomised clinical trials (RCTs) in ulcerative colitis (UC). Methods: We conducted an ... IPD meta-analysis using Vivli and Yale University Open Data Access data-sharing platforms. Phase 2 and 3 RCTs of advanced biologics in adults with moderate-to-severe UC published since 2010 were included. Pooled placebo rates and 95% CIs were estimated using one-and two-stage meta-analytical approaches. Significant patient-level factors (P < 0·05) were identified using regression analyses. Primary outcomes were clinical response and remission. Results: Data were available for 1703 patients from nine studies. For induction trials, overall placebo response and remission rates were 33% (95% CI 29%–38%) and 9% (95% CI 7%–11%). Overall placebo response and remission rates in maintenance trials were 28% (95% CI 18%–41%) and 14% (95% CI 9%–20%). A lower body mass index reduced odds of placebo response and remission, while higher baseline albumin levels and left-sided (compared to extensive) UC increased the odds of these outcomes. A one-point increase in the Mayo Clinic Score (MCS) and adapted MCS was associated with a 26% and 27% reduction in odds of clinical remission. For induction trials, prior biologic exposure was associated with lower odds of response and remission. Multi-centre trials have lower placebo effects than single-centre trials. Conclusions: These results enable future trials to incorporate design elements that reduce placebo rates as well as a precise benchmark for expected rates in clinical trials that do not include placebo.Vir: Journal of Crohn's and colitis [Elektronski vir]. - ISSN 1876-4479 (Vol.
, iss. , [article no.] jjaf191, 2025, str. ) Vrsta gradiva - e-članekLeto - 2025Jezik - angleškiCOBISS.SI-ID - 257167107
Avtor
Solitano, Virginia |
Hogan, Malcolm |
Singh, Siddharth |
Danese, Silvio |
Peyrin-Biroulet, Laurent |
Vuyyuru, Sudheer Kumar |
MacDonald, John K |
Zou, Guangyong |
Hanžel, Jurij
Teme
inflammatory bowel disease |
placebo effect |
clinical trials |
ulcerative colitis |
kronične vnetne črevesne bolezeni |
učinek placeba |
klinične raziskave |
ulcerozni kolitis
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
| Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
|---|---|---|---|---|---|---|---|---|
| JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP | |
Faktor vpliva
Baze podatkov, v katerih je revija indeksirana
| Ime baze podatkov | Področje | Leto |
|---|
| Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
|---|---|
| Solitano, Virginia | ![]() |
| Hogan, Malcolm | ![]() |
| Singh, Siddharth | ![]() |
| Danese, Silvio | ![]() |
| Peyrin-Biroulet, Laurent | ![]() |
| Vuyyuru, Sudheer Kumar | ![]() |
| MacDonald, John K | ![]() |
| Zou, Guangyong | ![]() |
| Hanžel, Jurij | 54194 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
| Mesto prevzema | Status gradiva | Rezervacija |
|---|
Prosimo, počakajte trenutek.
